Ask AI
Beyond Initial Response

CE / CME

Beyond Initial Response: Long-term Monitoring and Management in MASH

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: July 14, 2025

Expiration: July 13, 2026

Activity

Progress
1 2
Course Completed

How many people with metabolic dysfunction–associated steatohepatitis (MASH) do you provide care for in a typical week?

For those who practice in academic or community settings, please indicate your practice setting:

A 72-year-old adult with obesity (BMI 34.7 kg/m²), type 2 diabetes (T2D) (A1C 8.2%), and hypertension is newly diagnosed with MASH and F2 fibrosis based on vibration-controlled transient elastography (VCTE) findings. Current medications include metformin, lisinopril, and simvastatin. The patient is concerned about their liver disease and asks if there is a treatment option that could help address both their liver and metabolic health.

Which of the following is the most appropriate next step in this patient’s management?